HDL Cholesterol Subclasses
High Density Lipoprotein comprises a complex family of particles that vary in their lipid and protein composition. Cholesterol is a major component of HDL, and it can be directly measured as HDL-cholesterol. In clinical practice HDL-cholesterol, rather than HDL, is used to risk stratify patients for cardiovascular disease (CVD). HDL is considered ‘good’ cholesterol and is cardioprotective, therefore high HDL levels (> 40 mg/dL in men and > 50 mg/dL in women) confer a 20-40% decreased risk of CVD.
HDL transports cholesterol from non-hepatic cells to the liver, where it is degraded to release cholesterol for excretion through bile (reverse cholesterol transfer pathway). Nascent HDL secreted from the liver and intestine is disc-shaped and lacks cholesteryl ester in its core. The ABCA1 transporter promotes the efflux of excess cellular cholesterol in the extra-hepatic tissue to nascent HDL where cholesterol molecules are rapidly esterified by lecithin-cholesterol acyl transferase (LCAT). As nascent HDL accumulates the cholesteryl esters, it is converted to spherical, mature HDL.
Based on density gradient ultracentrifugation, HDL can be of two distinct subtypes; HDL2 (larger and buoyant, d = 1.063 – 1.125) and HDL3 (smaller and dense, d = 1.125 – 1.21). HDL2 is formed in circulation from HDL3 through the action of LCAT and HDL2 contains twice as many cholesterol molecules per unit of apolipoprotein compared to HDL3. These HDL subclasses are believed to play different roles in arteriosclerosis progression and regression. HDL2 has been suggested to be the more variable component of total HDL and several lines of evidence showed that it is the more anti-atherogenic form of HDL. Therefore, decreased levels of HDL2 cholesterol is associated with an increase in the risk of atherosclerotic cardiovascular disease.
- As an aid in diagnosis of atherosclerosis and cardiovascular disease
- Risk assessment for atherosclerosis and cardiovascular disease
HDL2 >16 mg/dL
HDL3 > 30 mg/dL
Serum or Plasma (EDTA, Sodium heparin).
Stability
- Ambient: 3-5 days
- Refrigeration: 5-7 days
- Frozen: 30 days
- Clin Biochem. 1999;32(2):149-52. [PMID: 10211633]
- Circulation. 1991;84(1):129-39. [PMID: 2060089]
- J Clin Lipidol. 2012;6(6):496-523. [PMID: 23312047]
- Atherosclerosis. 2011;214(1):196-202. [PMID: 21109246]
- Eur Heart J. 2015;36(1):22-30. [PMID: 24980493]
- Ann Clin Biochem. 1986;23 ( Pt 5):504-8. [PMID: 3767284]
- Sci Rep. 2020;10(1):8138. [PMID: 32424189]